Phyto-vesicles: Conduit between conventional and novel drug delivery system

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 3 SUPPL., 2012, Pages

  Mishra, Nidhi ^a   Yadav, Narayan P ^a   Meher, Jaya Gopal ^a   Sinha, Priyam ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Drug delivery system; Parenchymal cell; Phyto vesicles; Targeting

Indexed keywords

AMPELOPSIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BILBERRY EXTRACT; BREVISCAPINE; CATECHIN; COLCHICINE; CURCUMIN; DRUG CARRIER; EPIGALLOCATECHIN; FLAVONOID; GARLICIN; GLYCYRRHETINIC ACID; HERBACEOUS AGENT; LIPOSOME; PACLITAXEL; PHYTOVESICLE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; SERICOSIDE; SILIBININ; UNCLASSIFIED DRUG; USNIC ACID; VISNADEX; WOGONIN;

ANGINA PECTORIS; ARTEMISIA ARBORESCENS; ARTICLE; BILBERRY; CENTELLA; CHEMICAL ANALYSIS; CHEMICAL PARAMETERS; CONGESTIVE HEART FAILURE; CRATAEGUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG CARRIER INTERACTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; DRUG TARGETING; ECHINACEA; EDEMA; ENTRAPMENT EFFICIENCY; GINKGO BILOBA; GINSENG; GRAPE SEED; HEART ARRHYTHMIA; HUMAN; HYDROGEN BOND; HYPERTENSION; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LIPOSOMAL DELIVERY; MEDICINAL PLANT; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN DISEASE; SKIN IRRITATION; TRANSITION TEMPERATURE; VEIN DISEASE;

EID: 84875404209     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60485-7     Document Type: Article

References (42)

1. Jain NK Controlled and novel drug delivery 2005, 321-332. CBS Publisher, New Delhi. 1st ed.
2. Vinod Kr, Sandhya S, Chandrashekar J, Swetha R, Rajeshwar T, David B, et al. A review on genesis and characterization of Phyto-vesicles. Int J Pharm Sci Res 2010, 4(3):69-75.
3. Saraf Ajazddin S Applications of novel drug delivery system for herbal formulations. Fitotherapia 2010, 81:680-689.
4. Chanchal D, Swarnlata S Novel approaches in herbal cosmetics. J Cosmet Dermatol 2008, 7(2):89-95.
5. Bhattacharya S Phyto-vesicles: Emerging strategy in delivery of herbal drugs and nutraceuticals. Pharma Times 2009, 41(3):9-11.
6. Bombardelli E, Curri SB, Della R Loggia, Del NP, Tubaro A, Gariboldi P Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia 1989, 60:1-9.
7. Bombardelli E Phyto-vesicle: new cosmetic delivery system. Boll Chem Farmaceut 1991, 130(11):431-438.
8. Bombardelli E Phyto-vesicles in functional cosmetics. Fitoterapia 1994, 65(5):320-327.
9. Accessed- Sept 26, 2008. http://www.phospholipidsonline.com.
10. Bombardelli E, Spelta M Aging skin: protective effect of silymarin-Phyto-vesicles. Fitoterapia 1991, LXII(2):111-122.
11. accessed on May 21, 2010. http://www.Phyto-vesicles.info.
12. Kidd PM Bioavailability and activity of phyto-vesicle complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009, 14(3):226-246.
13. Bhattacharya S Phyto-vesicles: The new technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Res 2009, 2(3):225-232.
14. Flaig TW, Michael G, Daniel G, Adrie VB, Yuzhen T, Shandra W, et al. A phase I and pharmacokinetic study of silybin-phyto-vesicle in prostate cancer patients. Invest New Drugs 2007, 25(2):139-146.
15. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharm 1990, 15(4):333-338.
16. Gatti G, Perucca E Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidyl choline complex (silipide) in healthy volunteers. Int J Clin Pharmacol Ther 1994, 32(11):614-617.
17. Savio D, Harrasser PC, Basso G Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin. Arz forsc 1998, 48(11):1104-1106.
18. Hoh CS, Boocock DJ, Marczylo TH, Brown VA, Cai H, Steward WP, et al. Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites. J Agri Food Chem 2007, 55(7):2532-2535.
19. Marena C, Lampertico M Preliminary clinical development of silipide: a new complex of silybin in toxic liver disorders. Planta Med 1991, 57:124-125.
20. Jiang YN, Yu ZP, Yan ZM, Chen JM Studies on preparation of herba epimedii flavanoid Phyto-vesicles and their pharmaceutics. Zhongguo Zhong Yao Za Zhi 2001, 26(2):105-108.
21. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK Curcuminphospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007, 330(1-2):155-163.
22. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 2006, 58(9):1227-1233.
23. Yanyu X, Yunmei CS, Quineng ZP The preparation of silybinphospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006, 307(1):77-82.
24. Pandey Shivanand, Patel Kinjal Phyto-vesicles: a technical revolution in phytomedicine. Int J Pharm Tech Res 2010, 2:627-631.
25. Kidd P, Head K A review of the bioavailability and clinical efficacy of milk thistle Phyto-vesicle: a silybin-PC complex. Alter Med Rev 2005, 10(3):193-203.
26. Schandalik R, Perucca E Pharmacokonetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction. Drgs Exp Clin Res 1994, 20:37-42.
27. accessed on May 21, 2010. http://www.indena.com.
28. Sindhumol PG, Maria T, Mohanachandran PS Phyto-vesicles: A novel dosage form for enhancement of bioavailability of botanicals and nutraceuticals. Int J Pharm Pharmac Sci 2010, 3(4):10-14.
29. Morazzoni P, Montalbetti A, Malandrino S, Pifferi G Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharm 1993, 18:289-297.
30. Gupta NK, Dixit VK Bioavailability enhancement of curcumin by complexation with phosphatidylcholine. J Pharm Sci 2011, 100:1987-1995.
31. Changediya V, Khadke M, Devdhe S Phyto-vesicles: new approach for delivering herbal drug with improved bioavailability. Res J Pharm Bio Chem Sci 2011, 2(3):57-68.
32. Raj PV, Nitesh K, Chandrashekhar HR, Rao CM, Rao JV, Udupa N Effect of lecithin and silymarin on d-galactosamine induced toxicity in isolated hepatocytes and rats. Indian J Clin Biochem 2010, 25:169-174.
33. Pierro FD, Menghi AB, Barreca A, Lucarelli M, Calandrelli A GreenSelect® Phyto-vesicle as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Altern Med Rev 2011, 154-160.
34. Gupta NK, Nahata A, Dixit VK Development of a spectrofluorimetric method for the determination of curcumin. Asian J Trad Med 2010, 5:51-57.
35. Sharma A, Gupta NK, Dixit VK Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv 2010, 17:587-595.
36. Cui J, Yu B, Zhaoe Y, Zhua W, Li H, Lou H, et al. Enhancement of oral absorption of curcumin by self microemulsifying drug delivery systems. Int J Pharm 2009, 371:148-155.
37. Chen ZP, Sun J, Chen HX, Xiao YY, Liu D, et al. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 2010, 81(8):1045-1052.
38. Hüsch J, Dutagaci B, Glaubitz C, Geppert T, Schneider G, Harms M, et al. Structural properties of so-called NSAID-phospholipid-complexes. Eur J Pharm Sci 2011, 44(1-2):103-116.
39. Panda VS, Naik SR Cardioprotective activity of Ginkgo biloba Phyto-vesicles in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluation. Exp Toxicol Pathol 2008, 60(4-5):397-404.
40. Panda VS, Naik SR Hepatoprotective effect of Ginkgoselect Phyto-vesicle® in rifampicin induced liver injury in rats: Evidence of antioxidant activity. Fitoterapia 2008, 79(6):439-445.
41. Lu Y, Zhang Y, Yang Z, Tang X Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. Int J Pharm 2009, 366(1-2):160-169.
42. Javed S, Kohli K, Ali M Reassessing bioavailability of silymarin. Altern Med Rev 2011, 16(3):239-249.